)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company (874) investor relations material
Guangzhou Baiyunshan Pharmaceutical Holdings Company Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary21 Aug, 2026
Executive summary
Operating revenue for the first half of 2026 was RMB42.09 billion, up 0.61% year-over-year, while net profit attributable to shareholders fell 16.70% to RMB2.10 billion.
The group focused on biopharmaceuticals, healthcare, and innovation, expanding its product portfolio, R&D pipeline, and international presence.
Major activities included procurement reforms, product launches, digital transformation, and capital operations such as M&A and venture investments.
Financial highlights
Operating revenue: RMB42.09 billion (+0.61% YoY); net profit attributable to shareholders: RMB2.10 billion (−16.70% YoY).
Basic EPS: RMB1.289 (−16.70% YoY); gross profit margin: 17.10% (down 1.09 percentage points YoY).
Net cash flow from operating activities: −RMB269.95 million (improved from −RMB3.40 billion YoY).
Total assets: RMB87.82 billion (+3.92% from end-2025); net assets attributable to shareholders: RMB39.13 billion (+3.56%).
Outlook and guidance
Plans for H2 2026 include strengthening core business, accelerating R&D and innovation, expanding overseas, intensifying capital operations, and deepening digital transformation.
Focus on flagship products, new product launches, and international market penetration, especially in Vietnam, Malaysia, and Central Asia.
Impact of interest rate shifts on net profit
Strategic expansion into radiopharmaceuticals
International asset-light production status
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Guangzhou Baiyunshan Pharmaceutical Holdings Company
- Operating income rose 3.58% while net profit dipped 2.06% year-over-year in Q1 2026.874
Q1 2026 - Net profit rose 5.21% to RMB2.98B on RMB77.66B revenue, focusing on innovation and global expansion.874Q4 2025
- Q3 2025 delivered strong profit growth and EPS, despite a sharp drop in operating cash flow.874Q3 2025
- Revenue up 1.93% YoY, net profit down 1.31%, interim dividend RMB0.40 per share.874Q2 2025
- Net profit fell 37.82% in Q3 2024 as sales and margins declined under macroeconomic pressures.874Q3 2024
- Revenue up 2.68% but net profit down 9.31% amid higher costs and negative cash flow.874Q2 2024
- Revenue and net profit declined in Q1 2025, with cash flow pressures intensifying.874Q1 2025
- Net profit dropped 30% on flat revenue; 2025 focus is on supply chain and innovation.874Q4 2024
Next Guangzhou Baiyunshan Pharmaceutical Holdings Company earnings date
Q3 202627 Oct, 2026
Guangzhou Baiyunshan Pharmaceutical Holdings Company
Next Guangzhou Baiyunshan Pharmaceutical Holdings Company earnings date
Q3 202627 Oct, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage